Latest KFF Health News Stories
Trump Muddies Already-Delicate Situation With Suggestion To Repeal Now, Replace Later
The president’s tweet adds pressure to Republicans home for recess who were already going to face tough questions from voters.
During Recess, Governors Continue To Make Pitch Against Republicans’ Health Plan
Republican governors of states that expanded Medicaid fear the cuts in the Senate’s health bill would be devastating. On the other side of the debate, Indiana’s governor doesn’t get what he expects when soliciting Obamacare “horror” stories.
Some Republicans Keep Low Profile To Avoid Fireworks From Constituents Over Health Bill
Lawmakers are home for recess and some are ducking out of public events so as not to incur their voters’ wrath over the legislation.
Today’s early morning highlights from the major news organizations.
The Call-In: Answers To Questions About Our Business-Driven Health System
On NPR’s Weekend Edition Sunday, KHN’s Elisabeth Rosenthal answers questions about the high cost of U.S. health care, while NPR’s Gisele Grayson addresses how the Senate bill to replace the Affordable Care Act would change the system.
What Tax Breaks? Those Promised In GOP Plans Go Mostly To Top 1%
Similar to the House-passed American Health Care Act, the Senate GOP health bill would change or eliminate more than a dozen taxes that were put in place to help pay for provisions of the Affordable Care Act.
Should GOP Health Bill Prevail, Say Bye-Bye To Insurance Rebates
A little-noticed provision of the Senate GOP health plan would unwind an Affordable Care Act provision limiting insurer profits, administrative costs.
McConnell Has About $200B In ‘Candy’ To Make Deals On Obamacare Repeal
As many as a dozen GOP senators may oppose the Senate majority leader’s Obamacare repeal bill. But the dealmaking is just beginning.
Viewpoints: Patient Bigotry; The Hope And Hijinx Of Digital Health
A selection of opinions on health care from around the country.
Medicaid Meanderings: GOP Medicaid Plans – On The Right Track To Reform Or A Program ‘Sledgehammer’?
Opinion writers critique how the Medicaid program is handled in the GOP House and Senate health plans.
The opinions just keep coming as editorial writers struggle with the goings on surrounding GOP efforts to reach an intraparty consensus on health care.
Big Picture Perspectives: The Challenges Of Crafting Health Bills; Fine Lines And Hard Realities
Editorial pages across the country offer different views on the big-picture issues in play as congressional Republicans attempt to advance legislation to revamp the Affordable Care Act.
Research Roundup: Medicaid Costs For Opioid Addiction Medication, Health Exits
Each week, KHN compiles a selection of recently released health policy studies and briefs.
Media outlets report on news from Indiana, West Virginia, South Dakota, Maine, Maryland, Massachusetts, Florida, Pennsylvania, Missouri, Iowa and California.
‘It’s Getting Worse In Many Ways’: Health Professionals Try To Wrap Arms Around Opioid Epidemic
Media outlets report on the crisis out of Kansas and New Hampshire.
Record Low Fertility Rate Makes Some Experts Worry The Sky Is Falling
When it comes to sustaining a population, there’s a fine line between too many and not enough babies. America is edging toward the latter. In other public health news: cancer, freeze-dried placenta pills, treatment-resistant infections and Salvador Dalí.
Researches Caught Off-Guard As CMS Stops Release Of Highly Anticipated Medicare Data
The Ceners for Medicare & Medicaid Services said there were enough questions about the data’s accuracy that it should not be released for research use.
The merger was worth $9.4 billion.
Ohio Republicans Gird For Fight Between Governor And Legislature Over Medicaid
Gov. John Kasich is a strong supporter of the state’s Medicaid expansion but the lawmakers want to freeze it. News outlets also report on Medicaid issues in Montana and Georgia.
Hearings Over High Drug Prices Delayed Due To Partisan Atmosphere On Capitol Hill
Sen. Lamar Alexander of Tennessee says he’s frustrated with how Democrats are approaching the issue. The delay is a gift for the pharmaceutical industry, which has worked to put the brakes on a number of congressional and administrative efforts to bring down prescription drug prices.